Cover Image

Increased TRPV6 Potentiates Interleukin‐13 Signalling in Epithelial Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Fuying Cheng, Juan Liu, Chen Zhang, Qianqian Zhang, Jiani Chen, Yizhang Wang, Shirui Xue, Yufei Yang, Kai Xue, Huan Wang, Xicai Sun, Li Hu
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Clinical & Experimental Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study
by: Chen Zhang, et al.
Published: (2025)

Amphiregulin Mediates Epithelial Cell–Eosinophil Interactions and Amplifies Inflammation in Chronic Rhinosinusitis With Nasal Polyps
by: Limin Zhao, et al.
Published: (2025)

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes
by: Alessandra Vultaggio, et al.
Published: (2026)

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients
by: Sharon Van Nevel, et al.
Published: (2025)

Comparative Transcriptomic Analysis of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps ( CRSwNP ) Using Nasal Tissue and Brushing Samples
by: Daiki Nakashima, et al.
Published: (2026)

Natural Killer Cell Dysfunction Causes Eosinophil Accumulation in Chronic Rhinosinusitis With Nasal Polyps
by: Yohei Sato, et al.
Published: (2026)

Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
by: Mu Xian, et al.
Published: (2025)

Acetylcholine From Solitary Chemosensory Cell, Not Neuron, Regulates Basal Cell Fate Driving Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
by: Bowen Zheng, et al.
Published: (2025)

Distribution of Eosinophils Across Multiple Paranasal Sinuses Within Patients With Chronic Rhinosinusitis With Nasal Polyps
by: Aris I. Giotakis, et al.
Published: (2026)

Type 2 Inflammation‐Biased Arachidonic Acid Metabolite Regulates Mucosal Remodeling of Chronic Rhinosinusitis With Nasal Polyps
by: Ying Li, et al.
Published: (2026)

Lower Airway Conditions Contribute to the Prediction of Polyp Recurrence in Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma
by: Jiaxing Guo, et al.
Published: (2026)

Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps
by: Jing Song, et al.
Published: (2024)

Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
by: Shiru Cai, et al.
Published: (2025)

“Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps
by: P. E. Vonk, et al.
Published: (2025)

Trends in Dupilumab Utilization for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
by: Daniel Xiao, et al.
Published: (2024)

IL‐13‐Induced Periostin Expression is Increased in Eosinophilic Chronic Rhinosinusitis
by: Isao Suzaki, et al.
Published: (2025)

Asthma is Underdiagnosed and Often Uncontrolled in Preoperative Patients With Chronic Rhinosinusitis With Nasal Polyps
by: Emma Genberg, et al.
Published: (2024)

Impact of Sinus Surgery on Bacteriome Composition in Patients With Chronic Rhinosinusitis With Nasal Polyps
by: Maria Vorobeva, et al.
Published: (2025)

Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
by: Eugenio De Corso, et al.
Published: (2025)

Tissue‐Serum Metabolomics Identifies Lipid Signatures in Eosinophilic Chronic Rhinosinusitis
by: Yibo Liang, et al.
Published: (2026)

Prevalence of Cystic Fibrosis Carrier Status in Chronic Rhinosinusitis Without Nasal Polyp
by: Do‐Yeon Cho, et al.
Published: (2025)

Associations Between Blood Eosinophil Surface Proteins and Clinical Traits in Severe Asthma and Chronic Rhinosinusitis With Nasal Polyposis
by: Emeline Delaunay, et al.
Published: (2025)

Almost Half of the Dupilumab‐Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year
by: Josje J. Otten, et al.
Published: (2025)

Letter to the Editor Regarding “S100A9 Induces Tissue Remodeling of Human Nasal Epithelium in Chronic Rhinosinusitis With Nasal Polyp”
by: Yuqing Jiang, et al.
Published: (2025)

Improvement of Mixed Inflammatory Environment in Nasal Secretions of Diffuse Type 2 Chronic Rhinosinusitis With Nasal Polyps Under Dupilumab
by: Fabio S. Ryser, et al.
Published: (2026)

Reply to: Real‐World Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps
by: Christina Dorismond, et al.
Published: (2025)

Complement–Eosinophil Crosstalk Links Complement Activation to Fibrin Deposition in Eosinophilic Chronic Rhinosinusitis
by: Ryo Hasegawa, et al.
Published: (2026)

Postoperative Anti‐IgE Therapy for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Efficacy and Prognostic Factors
by: Xiaomei Yang, et al.
Published: (2025)

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
by: Joaquim Mullol, et al.
Published: (2026)

Asthma Outcomes Following Early Versus Delayed Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
by: Jamie R. Oliver, et al.
Published: (2025)

Immune Cell Infiltration in Eosinophilic and Non‐Eosinophilic Chronic Rhinosinusitis
by: Katarzyna Czerwaty, et al.
Published: (2025)

Response to the Letter Regarding “S100A9 Induces Tissue Remodeling of Human Nasal Epithelium in Chronic Rhinosinusitis With Nasal Polyp”
by: Sang Hyeon Ahn, et al.
Published: (2025)

Letter to the Editor Regarding “Real‐World Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps”
by: Yiheng Liu, et al.
Published: (2025)

Prospective Real‐World Outcomes of Endoscopic Sinus Surgery and Dupilumab in Severe Chronic Rhinosinusitis With Nasal Polyps
by: Nirushan Narendran, et al.
Published: (2026)

Excessive Endoplasmic Reticulum Stress in B Cells Associates With the Local Immunoglobulin Production in Severe Type 2 Chronic Rhinosinusitis With Nasal Polyps
by: Yanran Huang, et al.
Published: (2025)

A Multicenter, Randomized, Controlled Clinical Trial on the Efficacy and Safety of Eucalyptol, Limonene, and Pinene Enteric Capsules in the Treatment of Chronic Rhinosinusitis With Nasal Polyps Postoperatively
by: Yutong Sima, et al.
Published: (2025)

Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease
by: H. B. E. Elzinga, et al.
Published: (2025)

Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis
by: Jacquelyn K. Callander, et al.
Published: (2025)

Dupilumab Initiation for Surgically Refractory Chronic Rhinosinusitis With Nasal Polyps Is Associated With Differential Expression of CLC and Activation of Eicosanoid Pathways
by: Christina Dorismond, et al.
Published: (2025)

Response to the Editor Regarding: “In Office Sampling of Eosinophil Peroxidase to Diagnose Eosinophilic Chronic Rhinosinusitis”
by: Jacquelyn K. Callander, et al.
Published: (2025)